Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01386
|
|||||
| Drug Name |
Cefotetan
|
|||||
| Synonyms |
Cefotetanum; Apatef (TN); Cefotan (TN); Cefotetan (JP15/USP/INN); (6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Bacterial infections [ICD11: 1A00-1H0Z] | Approved | [1] | |||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H17N7O8S4
|
|||||
| Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O
|
|||||
| InChI |
InChI=1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/t13?,15-,17+/m1/s1
|
|||||
| InChIKey |
SRZNHPXWXCNNDU-RHBCBLIFSA-N
|
|||||
| CAS Number |
CAS 69712-56-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 575.6 | Topological Polar Surface Area | 321 | ||
| Heavy Atom Count | 36 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 15 | |||
| XLogP |
0.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
9103
, 7847326
, 7978881
, 11051543
, 11466501
, 11467621
, 11486281
, 15359621
, 34717168
, 46506572
, 48020449
, 48020450
, 48095951
, 48244839
, 48415722
, 49699096
, 50124222
, 50186741
, 56463651
, 57313480
, 92125572
, 92719732
, 93302793
, 93374658
, 93578304
, 103594731
, 103914470
, 104301116
, 121363243
, 124766176
, 124800749
, 126628099
, 136199027
, 137156467
, 137249718
, 141754331
, 144204232
, 152035519
, 162176887
, 162258056
, 163409419
, 164788214
, 175611876
, 179116605
, 184545873
, 184546368
, 185985468
, 196378900
, 226443050
, 241122609
|
|||||
| ChEBI ID |
CHEBI:3499
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Cefotetan was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.